Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Given that metformin is likely to have only a small impact on DPP4 activity, it is likely that the main impact of metformin on GLP-1 is to increase GLP-1 secretion
Potential Areas of Support with Medically Guided Weight Management Appetite regulation Healthy body composition when clinically appropriate Metabolic health Reduction in cravings Feelings of fullness Glucose and metabolic balance when appropriate Long-term weight management under clinical guidance Non-surgical, provider-directed treatment approach Personalized, clinician-guided care GLP-1 GLP-1based medications may be considered as part of a medically guided weight management plan when clinically appropriate
Why Wegovy Stands Apart: The Novo Nordisk Advantage Wegovy holds a unique position as the only semaglutide formulation approved solely for obesity management, rather than diabetes
When progress has stalled despite rest or rehab
Morning injections maximize hunger control during daytime eating, while evening injections shift suppression to nighttime
